Bath & Body Works, Inc. (NYSE:BBWI) Stock Holdings Increased by Cwm LLC

Cwm LLC boosted its position in Bath & Body Works, Inc. (NYSE:BBWI) by 255.3% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 18,022 shares of the company’s stock after buying an additional 12,950 shares during the period. Cwm LLC’s holdings in Bath & Body Works were worth $575,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in BBWI. Wellington Management Group LLP grew its holdings in Bath & Body Works by 14.9% in the 4th quarter. Wellington Management Group LLP now owns 131,732 shares of the company’s stock worth $5,686,000 after buying an additional 17,131 shares in the last quarter. GAMMA Investing LLC grew its holdings in Bath & Body Works by 75.7% in the 1st quarter. GAMMA Investing LLC now owns 1,116 shares of the company’s stock worth $56,000 after buying an additional 481 shares in the last quarter. Wedmont Private Capital bought a new position in Bath & Body Works in the 1st quarter worth approximately $425,000. Park Avenue Securities LLC grew its holdings in Bath & Body Works by 11.0% in the 1st quarter. Park Avenue Securities LLC now owns 6,700 shares of the company’s stock worth $335,000 after buying an additional 666 shares in the last quarter. Finally, Contravisory Investment Management Inc. bought a new position in Bath & Body Works in the 1st quarter worth approximately $487,000. 95.14% of the stock is owned by institutional investors.

Insider Activity

In other Bath & Body Works news, CEO Gina Boswell bought 6,000 shares of Bath & Body Works stock in a transaction dated Wednesday, October 9th. The stock was bought at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the acquisition, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

Bath & Body Works Stock Down 0.2 %

BBWI opened at $31.94 on Friday. The stock has a fifty day moving average of $30.92 and a 200-day moving average of $38.50. The firm has a market capitalization of $7.13 billion, a P/E ratio of 8.23, a PEG ratio of 0.94 and a beta of 1.77. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. On average, analysts expect that Bath & Body Works, Inc. will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were issued a $0.20 dividend. The ex-dividend date was Friday, August 23rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.50%. Bath & Body Works’s payout ratio is currently 20.62%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft decreased their price objective on Bath & Body Works from $57.00 to $54.00 and set a “buy” rating for the company in a report on Monday, August 26th. Bank of America cut their target price on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. Robert W. Baird cut their target price on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research report on Thursday, August 29th. Morgan Stanley cut their target price on Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating for the company in a research report on Thursday, September 5th. Finally, Evercore ISI cut their target price on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a research report on Wednesday, August 28th. Eight equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, Bath & Body Works currently has an average rating of “Moderate Buy” and a consensus target price of $42.35.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.